M. Nabeno

Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): a highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

H. Utsumi, S. Kiuchi, Yoshinobu Nakamaru, 2012, Bioorganic & medicinal chemistry.

Discovery of novel 2-(3-phenylpiperazin-1-yl)-pyrimidin-4-ones as glycogen synthase kinase-3β inhibitors.

Shinji Tanaka, T. Adachi, S. Yuki, 2017, Bioorganic & medicinal chemistry letters.

A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site.

Shinichi Ishii, Takashi Kadowaki, Ikuko Miyaguchi, 2013, Biochemical and biophysical research communications.

Fused bicyclic heteroarylpiperazine-substituted L-prolylthiazolidines as highly potent DPP-4 inhibitors lacking the electrophilic nitrile group.

Hiroshi Sakashita, Yoshiharu Hayashi, Ikuko Miyaguchi, 2012, Bioorganic & medicinal chemistry.

Heterogeneous environment of the S-H group of Cys966 near the flavin chromophore in the LOV2 domain of Adiantum neochrome1.

M. Sakurai, H. Kandori, S. Tokutomi, 2007, Biochemistry.

Discovery of novel 2-(alkylmorpholin-4-yl)-6-(3-fluoropyridin-4-yl)-pyrimidin-4(3H)-ones as orally-active GSK-3β inhibitors for Alzheimer's disease.

Shinji Tanaka, M. Okamoto, Hiroshi Tanaka, 2015, Bioorganic & medicinal chemistry letters.

Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): a highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

H. Utsumi, S. Kiuchi, Yoshinobu Nakamaru, 2012, Bioorganic & medicinal chemistry.

A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site.

T. Kadowaki, F. Akahoshi, S. Ishii, 2013, Biochemical and biophysical research communications.